Medical Marijuana in Canada: A Growth Industry

Oculis Holding AG Pioneers Genotype-Based Precision Approach to Dry Eye Disease Treatment
Source: Streetwise Reports (06/13/2026)

Oculis Holding AG launches the PREDICT-1 trial for licaminlimab, targeting patients with a specific TNFR1 genotype to address unmet needs in the large dry eye disease market.

read more >

MindBio Therapeutics Positions Voice AI Technology for Growth in Safety-Critical Sectors
Source: Streetwise Reports (06/12/2026)

Explore how MindBio Therapeutics is advancing voice-based AI detection for intoxication across mining, aviation, and other industries, backed by strong market trends and analyst targets.

read more >

ORIC Pharmaceuticals Positions for Growth in Expanding Oncology Market
Source: Streetwise Reports (06/10/2026)

Explore how ORIC Pharmaceuticals is advancing its oncology pipeline with key catalysts ahead, amid rising global demand for innovative cancer treatments and strong analyst support.

read more >

Cancer Drug Developer Shifts 70% of Spending to Research as AI Pipeline Progresses
Source: Streetwise Reports (06/05/2026)

Rakovina Therapeutics (TSX.V: RKV) reported lower net losses, reduced administrative spending, debt restructuring, financing activity, and progress across its AI-driven oncology pipeline in Q1 2026.

read more >

California Pharma Co. Tests Breakthrough Cancer Drug, Cuts Death Risk 60%
Source: Streetwise Reports (06/04/2026)

Revolution Medicines Inc.'s (RVMD:NASDAQ) daraxonrasib treats pancreatic cancer patients, doubling median survival. Analysts rate it a "Buy" with targets up to US$263.

read more >